HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William M Mitchell Selected Research

poly(I).poly(c12,U) (ampligen)

1/2020Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
6/2016Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
1/2012A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William M Mitchell Research Topics

Disease

5Neoplasms (Cancer)
09/2017 - 03/2010
4Infections
10/2014 - 04/2007
3Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2020 - 01/2012
2Chromosomal Instability (Chromosome Stability)
09/2017 - 01/2015
2Multiple Sclerosis
05/2010 - 01/2009
2Virus Diseases (Viral Diseases)
11/2007 - 08/2005
1Tongue Neoplasms (Tongue Neoplasm)
01/2022
1Osteoporosis
12/2019
1Wounds and Injuries (Trauma)
12/2019
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2016
1Nausea
12/2016
1Pain (Aches)
12/2016
1Constipation
12/2016
1Vomiting
12/2016
1Prostatitis
01/2015
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2015
1Hyperplasia
01/2015
1Lung Neoplasms (Lung Cancer)
12/2014
1Colorectal Neoplasms (Colorectal Cancer)
12/2014
1Pneumonia (Pneumonitis)
10/2014
1Human Influenza (Influenza)
02/2014
1Breast Neoplasms (Breast Cancer)
03/2010
1Melanoma (Melanoma, Malignant)
04/2007

Drug/Important Bio-Agent (IBA)

4Cell-Free Nucleic AcidsIBA
09/2017 - 03/2010
3poly(I).poly(c12,U) (ampligen)IBA
01/2020 - 01/2012
3Antiviral Agents (Antivirals)IBA
02/2014 - 08/2005
2Biomarkers (Surrogate Marker)IBA
01/2015 - 03/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2009
1SMM-189IBA
12/2019
1CannabinoidsIBA
12/2019
1Pharmaceutical PreparationsIBA
12/2019
1Estrogen ReceptorsIBA
12/2019
1Retinaldehyde (Retinal)IBA
12/2019
1Raloxifene Hydrochloride (Evista)FDA Link
12/2019
1CB2 Cannabinoid ReceptorIBA
12/2019
1Indicators and Reagents (Reagents)IBA
09/2017
1Opioid Analgesics (Opioids)IBA
12/2016
1Interferon-alpha (Interferon Alfa)IBA
10/2014
1Neuraminidase (Sialidase)IBA
02/2014
1VaccinesIBA
02/2014
1Immunoglobulin A (IgA)IBA
11/2007
1Influenza Vaccines (Influenza Vaccine)FDA Link
11/2007
1Poly IIBA
04/2007
1Interleukin-6 (Interleukin 6)IBA
04/2007
1Poly I-CIBA
04/2007
1Double-Stranded RNA (RNA, Double Stranded)IBA
04/2007
1Iron-Dextran Complex (InFed)FDA Link
08/2005

Therapy/Procedure

1Ligation
01/2022
1Immunotherapy
09/2017
1Aftercare (After-Treatment)
12/2016
1Ambulatory Care (Outpatient Care)
12/2016
1Palliative Care (Palliative Therapy)
12/2016
1Radiotherapy
12/2014
1Therapeutics
04/2007